Heart Disease Prevention Is Changing: What the New AHA Guidelines Mean for You

For years, heart disease prevention was often simplified to a narrow focus on cholesterol alone.

While cholesterol still plays an important role, today’s science shows us a much bigger story.

The latest guidance from the American Heart Association and cardiology experts reflects a more

complete view of cardiovascular risk: earlier screening, clearer treatment targets, and a more

personalized approach to prevention.

This is good news. It means we have better tools than ever to help prevent heart attacks, strokes,

and silent artery disease—and to help those who already have disease improve their trajectory.

Key Takeaways from the Updated American Heart Association Guidelines

Cholesterol Risk Is Broader Than LDL Alone

The new guideline recognizes that cardiovascular risk is influenced by more than LDL cholesterol. Other important contributors can include triglycerides, remnant cholesterol particles, and Lipoprotein(a). This reflects a more complete understanding of what drives plaque buildup over time.

Risk Assessment Starts Earlier

Heart disease develops quietly over decades, often long before symptoms appear. Because of

that, prevention is beginning earlier—sometimes in adults in their 30s and 40s—with more

attention on long-term and lifetime risk, not just what your numbers look like today.

Lifetime LDL Exposure Matters

It is not only your cholesterol today that matters, but how long it has been elevated over time.

Years of higher LDL cholesterol can gradually contribute to plaque buildup in the arteries.

Lowering risk earlier or more significantly may have powerful long-term benefits.

Clear LDL Targets Are Back

Specific LDL goals are again being emphasized to better match treatment intensity to risk:

• Under 100 mg/dL for many individuals

• Under 70 mg/dL for higher-risk patients

• Under 55 mg/dL for those with known cardiovascular disease or very high risk

  
  

ApoB Is Becoming More Important

ApoB is a marker that reflects the number of cholesterol-carrying particles that can enter artery

walls. It represents the atherogenic part of lipid particles, and it gives a clearer picture of risk

than LDL alone, especially when standard cholesterol numbers appear “normal.”

Lipoprotein(a) Should Be Checked

Lp(a) is a common inherited risk factor that can significantly raise cardiovascular risk. It is

largely determined by genetics and often goes undetected unless specifically measured. Many

experts now recommend checking it at least once in adulthood.

Coronary Calcium Scoring Helps Detect Silent Disease

A coronary artery calcium (CAC) scan is a quick, noninvasive CT scan that looks for calcified

plaque in the coronary arteries. It can identify silent disease before symptoms occur and may

help guide prevention and treatment decisions.

Risk Assessment Is More Personalized

Today’s prevention model looks beyond cholesterol alone and considers additional risk-enhancing factors such as:

• Family history of premature heart disease

• Metabolic syndrome or insulin resistance

• Chronic kidney disease

• Chronic inflammatory or autoimmune conditions

• Premature menopause or pregnancy-related complications

• Elevated triglycerides

• Elevated Lipoprotein(a)

• Elevated ApoB

• Elevated hs-CRP (inflammation marker)

• Coronary artery calcium score when appropriate

  
  

How We Approach This at Elevated Integrative Medicine

At Elevated Integrative Medicine, we stay current with the latest science and use a personalized prevention model that looks at the whole picture.

We aim to look inside the artery wall for early disease, identify each person’s potential root causes of risk, and treat the whole person, not just a lab value.

Each person’s plan is individualized based on their health history, family history, labs, imaging, lifestyle, and goals.

Depending on individual needs, we may focus on areas such as inflammation, blood sugar spikes, endothelial health, cholesterol particles, active plaque risk, dental health, nutrition, exercise, sleep, stress, supplements, and medications when appropriate.

The Bottom Line

Cardiovascular care is becoming smarter, more proactive, and more personalized.

That means more opportunity to identify risk early, improve health at any stage, and positively

change the course of disease, whether the goal is prevention, stabilization, or reversal.

Most importantly, this is a hopeful time in cardiovascular care. Heart disease remains the leading

cause of death in men and women, but with proactive care it can often be prevented, slowed,

stabilized, and significantly improved. In some cases, plaque progression may even be halted or

reversed.

Wherever you are today, there is real opportunity to improve your heart health, change your

trajectory, and create a healthier future.

And that is a message worth taking to heart. ❤️

Reference:

2026 Guideline on the Management of Dyslipidemia (American Heart Association) AHA

Guideline Reference

[Return to May Newsletter]